Durata Therapeutics Inc (NASDAQ:DRTX) Investor Alert: Lawsuit Filed to Halt the Takeover by Actavis Plc
An investor, who currently holds shares of Durata Therapeutics Inc (NASDAQ:DRTX), filed a lawsuit in effort to halt the proposed takeover of Durata Therapeutics Inc by Actavis plc for $23 per share.
View full press release